MARKER THERAPEUTICS, INC. Sale of Stock, Price Per Share
MARKER THERAPEUTICS, INC. (MRKR) had Sale of Stock, Price Per Share of $8.34 per share as of 2018-10-17, per its 10-K filed 2020-03-12.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2020-03-12
- 2018-10-17: Sale of Stock, Price Per Share $8.34.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2018-10-17 | $8.34 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |